{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:36:26Z","timestamp":1782203786753,"version":"3.54.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/grf.0b013e318248045b","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T03:09:28Z","timestamp":1329534568000},"page":"65-74","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of Ovarian Cancer in Young Women"],"prefix":"10.1097","volume":"55","author":[{"given":"DAVID M.","family":"GERSHENSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics 2011.","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-8-20210126","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2007.10.8738","article-title":"Management of ovarian germ cell tumors.","volume":"25","author":"Gershenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R5-8-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jncimonographs\/lgi011","article-title":"Fertility-sparing surgery for malignancies in women.","volume":"34","author":"Gershenson","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1002\/cncr.24461","article-title":"Fertility preservation in young women with epithelial ovarian cancer.","volume":"15","author":"Wright","year":"2009","journal-title":"Cancer"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000133484.92629.88","article-title":"Surgical staging of ovarian low malignant potential tumors.","volume":"104","author":"Rao","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R10-8-20210126","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/AOG.0b013e3181e7961d","article-title":"Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.","volume":"116","author":"Schmeler","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R11-8-20210126","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D","article-title":"Serous borderline tumors of the ovary with noninvasive peritoneal implants.","volume":"83","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"R12-8-20210126","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.","volume":"30","author":"Silva","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R13-8-20210126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2010.07.019","article-title":"Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.","volume":"119","author":"Shih","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R14-8-20210126","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1","article-title":"Ovarian serous borderline tumors with invasive peritoneal implants.","volume":"82","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"R15-8-20210126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ygyno.2010.11.035","article-title":"Overview of anti-angiogenic agents in development for ovarian cancer.","volume":"121","author":"Burger","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R16-8-20210126","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-8-20210126","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer.","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R18-8-20210126","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa067749","article-title":"High-dose chemotherapy and stem cell rescue for metastatic germ-cell tumors.","volume":"357","author":"Einhorn","year":"2007","journal-title":"N Engl J Med"},{"key":"R19-8-20210126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","article-title":"Recurrent low-grade serous carcinoma is relatively chemoresistant.","volume":"114","author":"Gershenson","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201203000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:55:00Z","timestamp":1618365300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201203000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e318248045b","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}